Laboratory News and Research

RSS

The role of UV-Vis in biopharma QC

UV-Vis and fluorescence support faster QC of nucleic acid and protein concentration.

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 20 Aug 2026

Review examines how medical imaging foundation models are moved toward clinical use

AI is already widely used for lesion detection, disease classification, and outcome prediction in medical imaging, but most systems remain narrowly designed for one task and depend heavily on expert-labelled data.

20 Aug 2026

AI-driven drug-target interaction prediction moves toward real-world workflows

Drug-target interaction prediction can help researchers explain mechanisms of action, identify candidate targets, reposition existing medicines and prioritize compounds before costly laboratory work.

20 Aug 2026

Brain organoid studies on the ISS move closer to new treatments

Research using human brain organoids onboard the International Space Station International Space Station (ISS) helped lead to the clinical trial of a potential therapy for Rett syndrome, a debilitating neurological disorder in children.

20 Aug 2026

Rapid test breakthrough could transform iron treatment worldwide

WEHI researchers have developed a blood test that can detect iron deficiency in minutes, overcoming key limitations of existing point-of-care diagnostics and potentially transforming how the condition is diagnosed and treated worldwide.

20 Aug 2026

More coffee, higher testosterone? This study found a more complicated picture

Higher habitual coffee intake was associated with a leaner body composition, lower circulating branched-chain amino acids, and distinct cardiometabolic patterns in 2,264 middle-aged Finnish adults. Hormonal associations differed by sex, with broader testosterone- and SHBG-related patterns in men and more limited SHBG-related changes in women.

20 Aug 2026

New studies reveal hidden control hub for MYC-driven cancers

In a rare pair of papers published back-to-back in the journal Genes & Development, research teams led by senior author Anindya Bagchi, PhD, associate professor in the Cancer Genome and Epigenetics Program at Sanford Burnham Prebys Medical Discovery Institute, establish a unified framework that governs one of cancer's most powerful master regulators.

19 Aug 2026

New genetic risk score uncovers hidden type 1 diabetes cases

Incorporating a genetic risk score into standard testing for a genetic form of diabetes which affects young people could identify hidden type 1 diabetes in around one in five patients with a negative genetic test.

19 Aug 2026

$Pomegranate-derived compound shows promise against preserved ejection fraction heart failure$

Pomegranate-derived compound shows promise against preserved ejection fraction heart failure

A compound produced in the body after eating pomegranates improves heart function by up to 80% in a type of heart failure with limited treatment options.

19 Aug 2026

Multi-organ chip uncovers key mechanisms behind cancer metastasis

Cancer spreading beyond the primary tumor – a process known as metastasis – is responsible for at least two-thirds of cancer deaths.

19 Aug 2026

New battery-free pacemaker harvests power from every heartbeat

A team of University of Wisconsin–Madison researchers has developed an implantable, battery-free pacemaker that's charged by a patient's heartbeat.

19 Aug 2026

Novel norovirus vaccine approach may be adaptable for other RNA viruses

Every RNA virus — from stomach bugs and influenza to chickenpox and the common cold — has its own story to tell, with a unique combination of symptoms, rates of transmission, duration, and chemical blueprint.

19 Aug 2026

Global study reveals rising chronic kidney disease burden in women

Chronic kidney disease is now the seventh leading cause of death among noncommunicable diseases globally, affecting 11–13% of the adult population.

19 Aug 2026

Study uncovers molecular mechanism behind age-associated skin inflammation

As we age, the skin loses part of its ability to regenerate, heal wounds, and maintain an effective barrier against the outside world.

19 Aug 2026

Qureight expands with addition of second site, to accommodate rapid growth and ongoing development of chest Foundation Model

Qureight, an end-to-end imaging company that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus on lung and heart disease, today announced the opening of its new office space in London, UK.

From Qureight 19 Aug 2026